Takeda Updates HEMOFIL® M and RECOMBINATE Availability for Hemophilia A Patients

Takeda Updates HEMOFIL® M and RECOMBINATE Availability for Hemophilia A Patients

The National Bleeding Disorders Foundation (NBDF) is alerting the community to updated information from Takeda Pharmaceutical Company regarding the discontinuation timelines for HEMOFIL® M and RECOMBINATE®, two therapies used to treat hemophilia A,

National Bleeding Disorders Foundation’s Matt Delaney Named City & State New York’s 2026 Albany 40 Under 40 List

National Bleeding Disorders Foundation’s Matt Delaney Named City & State New York’s 2026 Albany 40 Under 40 List
Government Relations Manager recognized as a rising star in New York State politics and advocacy, a journey that began with NBDF programs.

Exhibitor Spotlight: Spark Biomedical Selected for Wellcome Leap’s Program to Reduce Heavy Menstrual Bleeding

Exhibitor Spotlight: Spark Biomedical Selected for Wellcome Leap’s Program to Reduce Heavy Menstrual Bleeding
Spark Biomedical is developing innovative solutions to shorten the time it takes women with heavy menstrual bleeding to get effective treatment and care.

Tequila, Roundups, and Big Dreams: How Bleeding Disorders Orgs are Shaking Up Fundraising

Tequila, Roundups, and Big Dreams: How Bleeding Disorders Orgs are Shaking Up Fundraising
Alternative funding is key to ensuring chapter stability and advancing their mission, especially in today’s unpredictable landscape. Hear from NBDF’s CEO and chapter leaders as they explore creative strategies for securing non-industry funding and partnerships.

National Bleeding Disorders Foundation Hosts 76th Annual Bleeding Disorders Conference

National Bleeding Disorders Foundation Hosts 76th Annual Bleeding Disorders Conference
Marking the One-Year Anniversary of NBDF’s Inclusivity-Focused Rebrand, the Conference Will Feature Jeanne White-Ginder, an Exclusive Sneak Preview of the Ryan White Documentary, Sessions on Advocacy, Healthcare Access, and More.

NBDF Unveils THRIVE Campaign: Empowering Individuals with Bleeding Disorders through 6 Essential Steps

NBDF Unveils THRIVE Campaign: Empowering Individuals with Bleeding Disorders through 6 Essential Steps
The National Bleeding Disorders Foundation (NBDF) announces the THRIVE campaign to raise awareness and educate on living healthily with bleeding disorders. Discover six essential steps to empower individuals and families, offering resources to thrive daily.

NBDF News Mention: Sad News of a Mother Charged in Death of 3-Year-Old Chelsea Boy with Hemophilia

NBDF News Mention: Sad News of a Mother Charged in Death of 3-Year-Old Chelsea Boy with Hemophilia

Data provided by the National Bleeding Disorders Foundation (NBDF) was referenced recently in the coverage of a tragic case in Chelsea that took a dark turn for 3-year-old Yael Guardado Prudencio, a child with hemophilia and a seizure disorder.

Novo Seven Unavailable in 8 mg Vials Due to Supply Constraints Beginning in January 2024

Novo Seven Unavailable in 8 mg Vials Due to Supply Constraints Beginning in January 2024
Due to supply constraints, Novo Nordisk will be unable to provide the 8 mg vial of NovoSeven® RT from January until mid-2024. Importantly, the overall supply of NovoSeven® RT is expected to remain intact as other vial sizes are available.

Transgender Health and the Bleeding Disorders Community: An Interview with Mason Bobro

Transgender Health and the Bleeding Disorders Community: An Interview with Mason Bobro
November is recognized as Transgender Health Awareness Month. NBDF had a conversation with Mason Bobro, a transgender man with Factor 10 deficiency, who offered insight into the importance of highlighting the specific health care needs of the transgender community.

Embracing Change and Empowering Communities: 2023 Bleeding Disorders Conference

Embracing Change and Empowering Communities: 2023 Bleeding Disorders Conference
The National Hemophilia Foundation (NHF) is thrilled to announce the highly anticipated 2023 Bleeding Disorders Conference, set to take place from August 17-19 at the renowned Gaylord National Resort & Convention Center in National Harbor, MD. This year's conference promises to be a groundbreaking event, bringing together individuals affected by inheritable blood and bleeding disorders, health care professionals, and industry experts.

VWD Pre-Con

The von Willebrand disease (VWD) pre-conference brings together the VWD community to connect in a lively, engaging and supportive educational environment. This year, we will focus on the elements of reconnecting, rebuilding and refocusing as a community. We will explore the many ways that we as a community can help raise awareness of VWD and help those who are unaware of their status. We’ll also discuss new medical updates and NHF’s course of action with VWD. Sponsored by CSL Behring.

Navigating Virtual School At Home

During COVID-19, many children are now figuring out how to learn online through virtual schooling. Many parents and caregivers are now tasked with balancing work, online school, and child care. This session will discuss strategies, tips, and stories of how to navigate the online school and virtual learning with a child who has a bleeding disorder.

Meet NYLI

What does it mean to be a future leader of the Bleeding Disorders Community? Is it possible to make a difference at my chapter while I'm still a teen? If you're looking to get involved these questions are probably on your mind. Come meet members of NBDF's National Youth Leadership Institute (NYLI), who will share how they've been able to make a difference through Education, Advocacy, and Chapter Work training. Not only are they making a difference - they're leveling up in the real world as a result.